JP2021512894A5 - - Google Patents
Info
- Publication number
- JP2021512894A5 JP2021512894A5 JP2020542552A JP2020542552A JP2021512894A5 JP 2021512894 A5 JP2021512894 A5 JP 2021512894A5 JP 2020542552 A JP2020542552 A JP 2020542552A JP 2020542552 A JP2020542552 A JP 2020542552A JP 2021512894 A5 JP2021512894 A5 JP 2021512894A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- compound according
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023203652A JP2024023490A (ja) | 2018-02-07 | 2023-12-01 | 治療用化合物および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862627435P | 2018-02-07 | 2018-02-07 | |
| US62/627,435 | 2018-02-07 | ||
| PCT/US2019/016503 WO2019156929A1 (en) | 2018-02-07 | 2019-02-04 | Therapeutic compounds and compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023203652A Division JP2024023490A (ja) | 2018-02-07 | 2023-12-01 | 治療用化合物および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512894A JP2021512894A (ja) | 2021-05-20 |
| JP2021512894A5 true JP2021512894A5 (https=) | 2022-02-14 |
| JP7397797B2 JP7397797B2 (ja) | 2023-12-13 |
Family
ID=67548561
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542552A Active JP7397797B2 (ja) | 2018-02-07 | 2019-02-04 | 治療用化合物および組成物 |
| JP2023203652A Pending JP2024023490A (ja) | 2018-02-07 | 2023-12-01 | 治療用化合物および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023203652A Pending JP2024023490A (ja) | 2018-02-07 | 2023-12-01 | 治療用化合物および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11691962B2 (https=) |
| EP (1) | EP3749662A4 (https=) |
| JP (2) | JP7397797B2 (https=) |
| KR (1) | KR20200118088A (https=) |
| CN (1) | CN111902404A (https=) |
| AU (1) | AU2019217366B2 (https=) |
| BR (1) | BR112020016123A2 (https=) |
| CA (1) | CA3089970A1 (https=) |
| IL (2) | IL276563B1 (https=) |
| WO (1) | WO2019156929A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2733405C2 (ru) | 2014-02-07 | 2020-10-01 | Экзитера Фармасьютикалз Инк. | Терапевтические соединения и композиции |
| CA3089970A1 (en) | 2018-02-07 | 2019-08-15 | eXIthera Pharmaceuticals Inc. | Therapeutic compounds and compositions |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595532A (en) | 1983-02-02 | 1986-06-17 | University Of Notre Dame Du Lac | N-(substituted-methyl)-azetidin-2-ones |
| JP2002501081A (ja) | 1998-01-26 | 2002-01-15 | ビーエーエスエフ アクチェンゲゼルシャフト | トロンビンインヒビター |
| HUP0104308A3 (en) | 1998-06-25 | 2002-06-28 | Bristol Myers Squibb Co | Amidino and guanidino azetidinone derivatives as tryptase inhibitors, process for their preparation, pharmaceutical compositions thereof and intermediates |
| US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
| EP1099690A4 (en) | 1998-07-23 | 2001-10-17 | Shionogi & Co | MONOCYCLIC BETA LACTAM COMPOUNDS AND CHYMASE INHIBITORS THAT CONTAIN THEM |
| KR20060120601A (ko) | 2003-08-22 | 2006-11-27 | 데이진 화-마 가부시키가이샤 | 키마제 저해제를 유효 성분으로서 함유하는 약제 |
| EP1871741A4 (en) | 2005-04-04 | 2012-01-11 | Daiamed Inc | SUBSTITUTED AZETIDINONE |
| TW200745084A (en) | 2006-03-08 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| JP5756800B2 (ja) | 2009-06-16 | 2015-07-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体を調節するアゼチジン２−カルボキサミド誘導体 |
| NZ602266A (en) | 2010-02-11 | 2014-05-30 | Bristol Myers Squibb Co | Macrocycles as factor xia inhibitors |
| JP6033319B2 (ja) | 2011-10-14 | 2016-11-30 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 第ＸＩａ因子阻害剤としての置換テトラヒドロイソキノリン化合物 |
| SG11201406142XA (en) | 2012-03-27 | 2014-10-30 | Univ Duke | Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage |
| RU2733405C2 (ru) * | 2014-02-07 | 2020-10-01 | Экзитера Фармасьютикалз Инк. | Терапевтические соединения и композиции |
| US20190315711A1 (en) | 2016-12-23 | 2019-10-17 | Exithera Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| CA3089970A1 (en) | 2018-02-07 | 2019-08-15 | eXIthera Pharmaceuticals Inc. | Therapeutic compounds and compositions |
| JP2022506110A (ja) | 2018-10-30 | 2022-01-17 | エクセセーラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物および組成物 |
| CN113056263A (zh) | 2018-10-30 | 2021-06-29 | 艾克赛特赫拉制药有限责任公司 | 治疗化合物和组合物 |
| JP2022523712A (ja) | 2019-01-29 | 2022-04-26 | エクセセーラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物および組成物 |
-
2019
- 2019-02-04 CA CA3089970A patent/CA3089970A1/en active Pending
- 2019-02-04 KR KR1020207024907A patent/KR20200118088A/ko active Pending
- 2019-02-04 CN CN201980021810.6A patent/CN111902404A/zh active Pending
- 2019-02-04 EP EP19751349.2A patent/EP3749662A4/en not_active Withdrawn
- 2019-02-04 WO PCT/US2019/016503 patent/WO2019156929A1/en not_active Ceased
- 2019-02-04 BR BR112020016123-3A patent/BR112020016123A2/pt unknown
- 2019-02-04 AU AU2019217366A patent/AU2019217366B2/en active Active
- 2019-02-04 JP JP2020542552A patent/JP7397797B2/ja active Active
-
2020
- 2020-08-06 US US16/986,658 patent/US11691962B2/en active Active
- 2020-08-06 IL IL276563A patent/IL276563B1/en unknown
-
2023
- 2023-02-17 US US18/170,858 patent/US12152014B2/en active Active
- 2023-12-01 JP JP2023203652A patent/JP2024023490A/ja active Pending
-
2025
- 2025-12-21 IL IL325484A patent/IL325484A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| JP2004532250A (ja) | 線維性疾患又は他の適応症の治療方法 | |
| US20210261524A1 (en) | Therapeutic compounds and compositions | |
| JP2015164972A5 (https=) | ||
| RU2017114933A (ru) | Соединения и композиции для лечения или профилактики патологических состояний, связанных с избыточным отложением фибрина и/или образованием тромбов | |
| RU2012144332A (ru) | Циклоалкил-замещенное производное имидазола | |
| JP2011527675A5 (https=) | ||
| JP2021512894A5 (https=) | ||
| JP2019529460A5 (https=) | ||
| JP2022545158A5 (https=) | ||
| JP2024507414A5 (https=) | ||
| JP2009521472A (ja) | 心肺手術の合併症の予防としてのトロンビンレセプターアンタゴニスト | |
| JP2014500280A5 (https=) | ||
| JPH04503524A (ja) | 再潅流損傷の防止又は制限のための薬剤 | |
| US20210253550A1 (en) | Therapeutic compounds and compositions | |
| US20070259913A1 (en) | Prophylaxis of thromboembolic events in cancer patients | |
| JP2024023490A (ja) | 治療用化合物および組成物 | |
| JP2022506109A5 (https=) | ||
| US20060241084A1 (en) | Inhibition of vascular endothelial growth factor | |
| CN101489549A (zh) | 直接凝血酶抑制剂在心血管领域的新的适应症 | |
| CN108623591B (zh) | 一种哌尼诺安化合物的用途 | |
| RU2813780C2 (ru) | Терапевтические соединения и композиции | |
| WO2004032911A2 (en) | Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor | |
| JP2015526493A (ja) | 冠動脈バイパス移植術を受けることが予定されている患者の非ｓｔ上昇型急性冠症候群の治療において使用するためのオタミキサバン | |
| CN116134025A (zh) | 酰胺膦氧类衍生物及其制备方法和用途 |